Comments: US HB7640 | 2021-2022 | 117th Congress
Bill Title: To amend the Orphan Drug Act to reauthorize a program of grants and contracts for the development of drugs for rare diseases and conditions (commonly referred to as "orphan drugs").
Spectrum: Bipartisan Bill
Status: (Introduced - Dead) 2022-05-03 - Referred to the House Committee on Energy and Commerce. [HB7640 Detail]
Text: Latest bill text (Introduced) [PDF]
Spectrum: Bipartisan Bill
Status: (Introduced - Dead) 2022-05-03 - Referred to the House Committee on Energy and Commerce. [HB7640 Detail]
Text: Latest bill text (Introduced) [PDF]
PolitiCorps Conversations
Start PolitiCorps Debate| Title | PolitiCorps | Access | Comments | Views | Last Post |
|---|---|---|---|---|---|
| There are no visible public or private PolitiCorps discussions concerning the 2021 US Congress HB7640 at this time. | |||||
